Haemonetics Corp. (HAE)
70.14
-2.03
(-2.81%)
USD |
NYSE |
Jan 20, 16:00
70.14
0.00 (0.00%)
After-Hours: 16:23
Haemonetics Research and Development Expense (Quarterly): 14.52M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Abbott Laboratories | 748.00M |
| Solventum Corp. | 183.00M |
| DexCom, Inc. | 157.50M |
| Masimo Corp. | 30.50M |
| UFP Technologies, Inc. | -- |